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Self-regulation of autoreactive kidney-infiltrating T cells in MRL-lpr
nephritis. MRL-/pr kidney-infiltrating (KI) T cell clones (CD3 +, TCR
aJf3+, B220+, CD4—, CD8—) are autoreactive, exclusively proliferate
to renal tissues, and secrete interferon-y (IFN-y). We now report that
IFN-y treatment of tubular epithelial cells (TEC) decreases their ability
to induce K! T cell proliferation. The decreased ability of IFN-y..treated
TEC to induce T cell proliferation is evident by 24 hours and can be
restored by re-exposure to TEC not treated with IFN-y. IFN-y-treated
TEC supernatant does not diminish K! T cell proliferation and IFN-y-
treated TEC fixed with glutaraldehyde remain less capable of inducing
KI T cell proliferation. Although we have not identified the TEC surface
molecule(s) modified by IFN-y, neither class I, class II, ICAM-l nor
IFN-'y bound to the surface of TEC are responsible. In conclusion,
IFN-y induces a surface alteration(s) on TEC capable of limiting their
ability to induce K! T cell proliferation. The ability of autoreactive K!
T cells to release IFN-y represents a self-regulatory mechanism for
limiting T cell expansion.
Mice with the genetic mutation lpr develop an autoimmune
disease similar to systemic lupus erythematosus. There is a
prominent T cell infiltrate in the kidneys of MRL-lpr mice in the
interstitium and surrounding vascular walls. A large portion
(50%) of these T cells are CD4—, CD8— and bear pre-B cell
determinants (8220), while the majority of the remaining T cells
express CD4+ [1, 2]. We have previously reported the isolation
of TCR a/f3+ CD4— CD8— B220+ T cell clones from the
kidney cortical interstitium of MRL-Ipr mice with lupus nephri-
tis [3j. These kidney-infiltrating (KI) T cell clones are autore-
active, proliferate to MHC-restricted renal tissues including
tubular epithelial (TEC), but are not stimulated to divide when
co-cultured with cells derived from other tissues, In addition,
we reported that KI T cell clones release IFN-y, which induces
class II and intercellular adhesion molecule-l (ICAM-l) expres-
sion on TEC. Both class II and ICAM-l molecules are ex-
pressed on the TEC in MRL-lpr mice prior to the loss of renal
function [41. Therefore, our previous studies suggest that IFN-y
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secreted by K! T cells induces autoreactivity and, in turn, tissue
injury.
Autoreactive T cells can promote renal injury [5—9]. How-
ever, mechanisms that regulate autoreactive T cells may take
place to limit their expansion within the target organ. T cell
autoreactivity may be dampened by antigen presenting cells.
For example, T cell unresponsiveness or anergy can be induced
by engagement of the TCR and MHC class II molecules,
without a co-stimulatory signal imparted by the antigen present-
ing cell [10]. Alternatively, autoreactive T cells may secrete a
cytokine directly responsible for self-regulation.
We now report that KI T cell clones are capable of controlling
their own autoreactivity. We have established that KI T cell
clones release IFN-y, which in turn is responsible for decreas-
ing the ability of TEC to promote KI T cell proliferation. This
reduction in K! T cell proliferation is not permanent since these
KI T cell clones again proliferate upon co-culture with TEC
which were not treated with IFN-y. Our data suggest that
IFN-y changes a TEC membrane property which otherwise
promotes K! T cell proliferation. In conclusion, we speculate
that autoreactive K! T cells possess the capacity to limit their
own expansion in the renal interstitium.
Methods
Animals
MRLIMpJ-Ipr-lpr (MRL-lpr) (H2k) mice were obtained from
Jackson Laboratory (Bar Harbor, Maine, USA) and maintained
in our animal facility.
Reagents and mAbs
The following commercial reagents were purchased: recom-
binant murine IFN-'y from Genetech (South San Francisco,
California, USA), anti-murine IFN-y from Lee Biomolecular
Research Inc. (San Diego, Caiif'ornia, USA), anti-transforming
growth factor-beta (TGFP) 2 antibody from Genzyme (Cam-
bridge, Massachusetts, US!). ti.sue culture media and supple-
ments from Gibco (Grand lsLin, New York, USA), 3H-
thymidine from New Englani "luclear (Boston, Massachusetts,
USA), hybridomas 10.2.16 (an' -LA1j and l4.4.4S (antiIEk)
from American Type Culture Cilction (Rockville, Maryland,
USA), purified anti-H-2' (hybridoria 11-4.1) from Becton and
Dickinson (LaJolla, California, USA). Hybridoma YNI/l.7.4
(anti-mouse ICAM-l) was provided by Dr. F. Takei, British
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Columbia Cancer Research Center, Vancouver, British Colum-
bia, Canada, and hybridoma SXC-1 (anti-mouse IL-b) was
provided by Dr. T. Mosmann, University of Edmonton, Al-
berta, Canada.
Cells
KIT cell clones (CD3+ TCR aJf3 + B220+ CD4— CD8—) and
TEC clones from MRL-lpr mice were obtained, characterized
and maintained in culture as described [3]. Briefly, K! T cell
clones were isolated from the cortical interstitium of MRL-/pr
mice four months of age and cultured in RPMI-1640 with 10%
fetal calf serum, 100 pg/mi streptomycin, 100 U/mi penicillin, 10
LM HEPES, 1 m sodium pyruvate, i0 M 2-mercaptoethanol
and 1% minimal essential amino acids (complete RPMI) using
as a feeder layer irradiated (3000 rads) syngeneic spleen cells
and TEC. TEC clones were prepared from kidney cortex from
MRL-lpr mice three months of age by collagenase dispersion
and sequential sieving through steel meshes. TEC were grown
in modified K! media [1:1 mixture of Dulbecco's modified
Eagle's medium (DMEM) and Ham's Fl2, containing the
following additives: 25 m'vi HEPES, 100 U/mi penicillin, 100
mg/mI transferrin, 1 ng/ml prostaglandin El, 5 x lO M
triiodothyronine, bO_8 M sodium selenite, 5 x l0 M hydro-
cortisone, 25 ng/ml epidermal growth factor] and cloned by
limiting dilution. TEC displayed alkaline phosphatase reactivity
and expression of class II and ICAM-l when in culture for three
days with IFN-y (250 U/mi).
Generation of SN from IFN--y treated TEC and KI T cell
clones
Subconfluent TEC were cultured in K-i media supplemented
with 250 U/mi of IFN-y for three days. KI T cell clones (1 x
l06/ml) were cultured in complete RPMI for three days. SN was
then harvested unfiltered, aliquoted in siliconized tubes, and
stored at —70°C until use.
Cell viability evaluation by Trypan blue exclusion
K! T cell clones were incubated in 96-well plates with
irradiated TEC previously treated or not with IFN-y (250 U/mI)
for 72 hours. The cells were harvested by pipetting three days
later and diluted 1:2 with 0.1% Trypan blue in PBS. Viable and
dead cells were counted with a hemocytometer, and the per-
centage of specific cell death was calculated according to the
following formula: % specific cell death = 100 x cells stained
with Trypan blue/total number of cells.
Glutaraldehyde fixation
TEC were washed three times with phosphate-buffered saline
and incubated with freshly prepared 4% glutaraldehyde for 15
minutes at 25°C. After incubation in fixative, the cells were
washed three times in RPMI and incubated for two hours at
37°C. At this time the cells were washed again three times with
complete RPMI and used for the proliferation assays.
Proliferation assays
K! T cell clones or freshly isolated KI T cells (1 X i0) were
cultured in complete RPMI medium alone or with irradiated
(3000 rads) syngeneic TEC in 96-well tissue culture wells in a
final volume of 200 d. All assays were performed in triplicate.
Cells were cultured for three days, pulsed with 1 pCi 3H-
thymidine during the last six hours of culture and harvested
with a semiautomated cell harvester (PHD, Cambridge, Massa-
chusetts, USA). 3H-thymidine incorporation was measured by
liquid scintillation counting.
Flow cytometric analysis
Cultured TEC (2.5 x l0) were suspended in 50 d Hank's
balanced salt solution containing 0.1% sodium azide and 3%
horse serum and incubated for 30 minutes at 4°C with 5 pg of
purified mAb or 50 d cell culture supernatant. TEC were
washed and incubated with the appropriate fluorescein conju-
gated second antibody for 30 minutes at 4°C. The cells were
washed, resuspended in 2% paraformaldehyde and analyzed on
a Epics flow cytometer (Coulter Electronics, Hialeah, Florida,
USA).
Statistics
Statistical analysis was performed using Statview SE + (Aba-
cus Concepts, Berkeley, California, USA). Differences be-
tween groups were compared by unpaired t-tests or one-way
ANOVA. All results are expressed as mean 1 SEM.
Results
IFN-y treated TEC clones and primary cultured tubular cells
lose their ability to induce the proliferation of KI T cell
clones and freshly isolated KI T cells
KI T cell clones are autoreactive and proliferate to renal
TEC. These T cells are responsible for secreting IFN-y which
induces class II and ICAM-l on TEC [11, 12]. To investigate
whether IFN-y treated TEC modified the proliferative response
of KI T cell clones, TEC were cultured in K-i media 250
U/mi IFN-y for three days. TEC were then irradiated and
served as target cells in a proliferation assay with KI T cell
clones as responder cells (Fig. 1A). IFN-y treated TEC were
less capable of inducing proliferation of autoreactive KI T cell
clones as compared with untreated TEC (P < 0.02). Thus,
IFN-y treated TEC lose their ability to stimulate KI T cell
proliferation.
To insure that our TEC clones in long-term culture were
representative of TEC, we investigated whether freshly isolated
primary TEC cultures stimulated with IFN-y reduced KI T cell
proliferation. Primary TEC treated with IFN-y and subse-
quently co-cultured with the K! T cell clone, H-b, reduced the
proliferation of the H-b clone (Fig. 1B). In addition, when
primary TEC were stimulated with IFN-y and then co-cultured
with freshly isolated KI T cells (90% expressed Thy 1.2 and
CD3) the freshly isolated K! T cells demonstrated a similar
reduction in proliferation as occurred using K! T cell clones
(data not shown).
Since KI T cell clones release IFN-y, we investigated
whether TEC stimulated with supernatants (SN) from KI T cell
clones diminish K! T cell proliferation. SN were obtained from
a 72 hour culture of 1 x 106 T cells/ml from three different KI T
cell clones. TEC were cultured with each SN for two days, and
then tested in the proliferation assay. Incubation with the SN
derived from these T cell clones decreased the ability of the
TEC to induce K! T cell clone proliferation (Fig. 2A). To
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investigate whether IFN-y was the cytokine in the SN respon-
sible for reducing T cell proliferation, TEC were cultured for
two days with SN derived from T cell clone H-b saturating
concentrations of anti-IFN-y mAb. The proliferation of K! T
cell clone H-b to TEC was restored when anti-IFN-ymAb was
added to the SN (Fig. 2B). Therefore, IFN-y in K! T cell SN is
responsible for decreasing the ability of TEC to stimulate
autoreactive T cell proliferation.
TEC treated with IFN-y lose their capacity to induce KI T
cell proliferation 24 hours after treatment
To investigate the kinetics of the loss of IFN-y-treated TEC
to induced K! T cell proliferation, TEC were grown in K-i
medium and IFN-y (250 U/mI) was added at various time-points
up to 72 hours. TEC incubated with IFN-y for more than 72
hours decreased in viability (data not shown). The maximal
effect of IFN-y on TEC was reached 24 hours after treatment
(Fig. 3A). The capacity of TEC to trigger T cell proliferation
was decreased at 125 U/mI of IFN-y, and was not further
augmented at concentrations up to 500 U/mI (Fig. 3B). Doses of
IFN-y > 500 U/ml decreased the viability of TEC (data not
shown).
Fig. 1. IFN--y treated TEC clones and
primary cultures lose their ability to induce KI
T cell proliferation. A. KI T cell clones (I x
F * i0 cells/well) were placed in culture for 3J days with an irradiated TEC clone previously(3 days) in culture in K-i media without (,
TEC) or with ( TEC-IFN-y) IFN-y (250 UI
_______
—p ml). B. KI T cell clone H-l0 (1 )< iO cells-
- * well) was cultured for 3 days with irradiatedI freshly isolated TEC (primary culture) or a
___________
TEC clone, 2B9. TEC were previously
cultured for 3 days in K-I media IFN-y
(250 U/mI). Similar results were obtained in
three separate experiments; each experimental
point was analyzed in triplicate. * P < 0.02.
The kinetics of IFN-y induced class II on TEC have been
well-established [12]. Therefore, we analyzed the loss in the
ability of TEC to induce K! T cell proliferation using the same
doses and time points that induce class II molecules on TEC.
The dose required to produce maximal class II expression on
TEC and to render TEC incapable of inducing KI T cell clone
proliferation was identical (125 U/mi). However, the time
required to produce a detectable increase in class II molecules
of TEC was twice as long (2 days) as the time required to detect
a loss in the ability of TEC to induce K! T cell proliferation (1
day) (data not shown).
Reduction of KI T cell clones proliferation by IFN-y
stimulated TEC is not due to decreased T cell viability
To investigate whether the decrease in K! T cell proliferation
to IFN-y treated TEC was a result of T cell death, the
percentage of viable cells was determined by Trypan blue
exclusion, K! T cell clones were cultured for 72 hours with TEC
which were previously cultured with 250 U/ml of IFN-'y for
three days. K! T cell clones were harvested, stained with
Trypan blue and the viability was calculated. There was no
difference in the percent viability of KI T cell clones cultured
A
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with TEC stimulated with IFN-y as compared with untreated
TEC (Table 1). Therefore, the reduction of KI T cell clone
proliferation is not due to the loss of T cell viability.
K! T cell proliferation reduced by IFN--y stimulated TEC is
restored when these cells are re-cultured with untreated TEC
To test if the KI T cell clones could be restimulated to fully
proliferate after exposure to IFN-y treated TEC, a T cell clone,
H-b, was co-cultured with IFN-y treated TEC for three days
and then subsequently re-cultured with untreated TEC. After
an additional three days, proliferation of T cells was measured
by 3H-thymidine incorporation. H- 10 T cell clone proliferation
was restored to the same level as originally induced by un-
treated TEC (Fig. 4). Hence, the reduction in the ability of
IFN-y treated TEC does not render the KIT cells unresponsive
to restimulation and is a transient event that is reversed when
KI T cells are re-stimulated with TEC which were not treated
with IFN-y.
The decrease in the ability of IFN-y treated TEC to induce
KI T cell proliferation requires a cell membrane interaction
We next evaluated whether the diminished proliferation of K!
T cell clones to TEC stimulated with IFN-y was caused by a
factor released by these cells or by cell contact. TEC either
treated or not treated with IFN-y were fixed with 4% glutaral-
dehyde prior to the addition of K! T cell clones in order to
prevent the release of soluble cytokines [13]. K! T cell clones
had a similar proliferation to TEC regardless of whether they
were treated with IFN-y. Fixation with glutaraldehyde did not
alter these results (Fig. 5). Moreover, SN derived from TEC
treated with IFN-y added to KI T cell clones co-cultured with
TEC which were not treated was unable to reduce T cell
proliferation (data not shown). Thus, the loss in the ability of
TEC treated with IFN-y to induce K! T cell clone proliferation
is related to a cell surface alteration and is not caused by a
molecule(s) secreted from TEC.
B
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Fig. 2. K! T cell clones secrete JFN-'j which
______________________________ can diminish the ability of TEC to induce K!
________
Tcell proliferation. A. K! T cell clone H-b
__________________________________
(I x IO cells/well) was cultured for 3 days
* with irradiated TEC previously (2 days) in
culture in K-l media IFN-y (250 U/mI)
SN (25% vol/vol) derived from a 3 day culture
of Kb T cell clones H-9, H-b, H-li. * p <
0.05. The experiment was repeated at least 2
times with similar results. B. KI T cell clone
H-b (1 x iO cells/well) was cultured for 3
__________________________________________
days with irradiated TEC previously (2 days)
in culture in K-I media IFN-y(250 U/mI)0 2 4 6 8 10 12 H-b clone SN (25% vol/vol) saturating
concentrations of anti-IFN-y mAb. * R <
cpm x l0 0.05.
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Fig. 3. Time-course and dose-response of IFN-y dependent reduction
of KI T cell proliferation. TEC were cultured in K-I media and IFN-y
(250 U/mI) was added at various time points from 1 to 72 hours A or at
various doses (0 to 500 U/mI) for 3 days B. TEC were then irradiated
and co-cultured (5 x 104 cells/well) with K! T cell clone H-b (1 X iO
cells/well) in 96-well/plates for 3 days. The experiment was repeated
three times with similar results. * P < 0.002. * P < 0.001.
Table 1. Reduction of KI-T cell proliferation after co-culture with
IFN-y stimulated TEC is not due to T cell death
K!. T cell
% Cell death
TEC-
clones TEC IFN-y P
E-12 8.0 2.6 8.3 2.1 NS
H-6 5.3 0.6 6.3 1.6 NS
H-9 6.1 0.2 5.9 1.5 NS
H-b 6.3 1.5 4.3 1.6 NS
H-Il 3.7 0.6 6.3 1.5 NS
Results are expressed as media 1 SEM of 3 different experiments.
K! T cell clones (1 x 106/ml) cultured for 3 days in 96-well plates with
irradiated TEC/TEC-IFN-y (5 x l05/ml). TEC were previously in
culture 3 days in K-I media. TEC-IFN-y were previously in culture 3
days in K-I media + IFN-y 250 U/mI.
o 15-
x -
E
-0
5-
0
cRPMI TEC
Fig. 4. K! T cells co-cultured with !FN-y treated TEC can again
proljferate when re-exposed to TEC nontreated with !FN-y. K! T cell
clone H-b (1 x l0 cells/well) was placed in culture for 3 days with
irradiated TEC previously (3 days) in culture in K-I media without
(H-b + TEC; P1) or with (11-10 + TEC-IFN-y; ) IFN-y. T cells were
then recovered and cultured for an additional 72 hours with irradiated
TEC which were not exposed to IFN-y. The experiment was repeated
three times with similar results.
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0 2 4 6 8 10 whether the interaction of MHC class I, class II or ICAM-1 with
its ligands contributed to the decreased ability of IFN-y treated
cpm x 1 0 TEC to trigger K! T cell proliferation. In addition, since IFN-y
can induce MHC and ICAM- 1 molecules on TEC, we investi-
gated whether the interaction of MHC class I, class II or
ICAM- I with its ligands contributed to the decreased ability of
IFN-y treated TEC to trigger KI T cell proliferation. The
amount of mAb against class I, class II and ICAM-1 required to
saturate TEC cell surface expression was assessed by flow
cytometry. IFN-y treated TEC incubated with saturating con-
centrations of mAb against class I, class II or ICAM-1 prior to
co-culture with the K! T cell clone, H-to, did not preserve the
ability of IFN-y treated TEC to induce K! T cell proliferation.
Thus, the decreased capacity of TEC treated with IFN-y to
_________________________
induce K! T cell clone proliferation is not mediated by class I,
class I! or ICAM- 1 antigens that are displayed on the surface of
_________________________________________________
TEC (Fig. Sb).
Class I, class II or ICAM-1 mAbs do not restore the capacity
of IFN-y treated TEC to induce K! T cell proliferation
K! T cell clones do not express CD4 or CD8 surface deter-
minants, but they do display other surface molecules involved
in T cell activation, including LFA-1, the ligand of !CAM-1. T
cells that do not express CD4 or CD8 molecules may be class I
or class II restricted [14, 15]. In addition, since IFN-y can
induce MHC and ICAM-1 molecules on TEC, we investigated
Surface bound IFN-y on TEC is not responsible for reducing
KI T cell clone prol(feration
Since IFN-y is capable of inhibiting T cell proliferation [16],
we investigated whether the decrease in K! T cell proliferation
induced by TEC treated with IFN-y was caused by the binding
of IFN-y to the cell surface. TEC incubated with IFN-y for
three days had a sparse amount of detectable IFN-y (7%) on the
surface of TEC by flow cytometric analysis. In addition, TEC
treated with IFN-y and then incubated with saturating concen-
trations of anti-IFN-y mAb for one hour prior to co-culturing
with K! T cell clones did not restore proliferation (Fig. 6).
Therefore, IFN-y displayed on the surface of TEC is not
responsible for diminishing K! T cell proliferation.
Neither TGFI3 nor IL-JO induced by IFN-y on TEC are
responsible for the loss of T cell clone proliferation
To eliminate the possibility that TGF/3 or IL-b were induced
by IFN-y on TEC, and were in turn responsible for decreasing
A TEC IFN-y Fixation
.+
+
6 — +
+ + +
E-12 H-6 H-9 11-10 H-il
Kl T cell clones
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KI T cell proliferation, saturating concentrations of anti-TGF/3
or IL-b neutralizing antibody were added to the K! T cell
clones co-cultured with IFN-y treated TEC. As compared with
the KI T cell clone (H 10) proliferation to TEC not treated with
IFN-y (13.4 1.2 x iO cpm), IFN-y treated TEC caused a
dramatic reduction in KI T cell proliferation (2.4 0 x l0-
cpm) which was not restored upon the addition of anti-TGFJ3
antibody (3.1 1.3 x b0 cpm) or anti-IL-lO mAb (3.7
0.7 x l0 cpm; P 0.01). Thus, neither TGF nor IL-b
displayed on the TEC are responsible for the diminished
proliferation of KI T cells to IFN-y treated TEC.
Discussion
The present report establishes that IFN-y treated TEC lose
their capacity to stimulate the proliferation of autoreactive T
cells that infiltrate the renal interstitium in MRL-/pr lupus
nephritis. The loss of KI T cell proliferation to TEC following
treatment with IFN-y is not permanent since K! T cell prolif-
eration is fully restored upon re-exposure to TEC not treated
Fig. S. The loss of the ability of IFN--y
trea ted TEC to induce KI T cell proliferation
is not due to a molecule(s) released by the
TEC and was not related to class I, class ii
or ICAM-1 expression. A. TEC previously in
culture for 3 days in K-i media alone or with
IFN-y (250 U/mI) (TEC-IFN-y) were fixed in
giutaraldehyde as described in the Methods.
These cells were then irradiated and co-
cultured (5 x l0 cells/well) with K! T cell
clone H-b (I x io cells/well) in 96-well/
plates for 3 days. Control experiments were
performed using non-fixed TEC and non-fixed
TEC-IFN-y. Similar results were found in
three experiments. * P < 0.001. B. IFN-y
treated TEC (TEC-IFN-y) were pre-treated
with saturating concentrations of anti-class I
(anti-H-2k), anti class II (1-Ek, I-Ak) and
ICAM-l mAbs for 1 hour prior co-cultured
(5 x jØ4 cells/well) with H-b T cells (1 x l04 cells/well) in 96-well/plates for 3 days. Similar
results were obtained in other three different
experiments. * P < 0.001.
with IFN-y. The decreased capacity of IFN-y treated TEC to
induce K! T cell proliferation is achieved by 24 hours after
stimulation and is not dependent on MHC or ICAM-l on the
TEC membrane. Given that: (1) KIT cell clones secrete IFN-y,
(2) SN from KI T cell clones incubated with TEC can mimic the
decreased ability of IFN-y treated TEC to induce K! T cell
proliferation, and (3) KI T cell clone SN incubated with
neutralizing amounts of anti-IFN-ymAb preserves the ability of
SN-treated TEC to induce K! T cell clone proliferation, we
hypothesize that autoreactive K! T-cells can limit their own
expansion.
In normal circumstances, TEC are required to process and
present an exogenous antigen to activate T cells [12, 13]. By
comparison, KI T cells do not require the presence of an
exogenous antigen to be induced to proliferate against TEC,
and are capable of proliferating to an endogenous antigenic
molecule constitutively present on the surface of TEC from any
MHC restricted mouse strain. Since IFN-y treated TEC lose
their ability to cause K! T cell clones to proliferate, it is possible
B TEC IFN-y mAb
+ —
+ +
+ + H2k
+ + lEk
+ + lAk
+ + CAM-i
II:
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that IFN-y alters an endogenous antigen on the surface of TEC
to which the KI T cell clones respond. An example of this
mechanism has been reported in autoimmune thyroiditis, in
which IFN-y is capable of reducing the expression of the
antigen responsible for the autoimmune tissue injury [17, 18].
By extension, IFN-y may also reduce the expression of a TEC
surface molecule(s) or autoantigen(s) involved in T cell activa-
tion.
Since IFN-y can directly inhibit T cell proliferation, the
possibility of a direct reduction of KI T cell proliferation by
IEN-y bound to the surface of TEC had to be eliminated. We
detected only a sparse amount of IFN-y on the surface of TEC
following incubation with IFN-y. Moreover, neutralizing IFN-y
with anti-IFN-y mAb did not restore the proliferation of K! T
cells to TEC. Therefore, we conclude that IFN-y on the surface
of TEC did not directly reduce K! T cell proliferation.
Since cytokines (IL-b, TGF/3) can prevent T cell activation,
we explored the possibility that either of these cytokines
induced by IFN-y on TEC was responsible for reducing K! T
cell proliferation. Although TGF/3 is secreted by TEC [19],
incubation of IFN-y treated TEC with anti-TGF/3 antibody did
not restore the loss of the ability of TEC to induce KI T cell
proliferation. We are also able to eliminate the possibility that
IL-b is responsible for reduced K! T cell proliferation. IL-b
mRNA is not detectable in TEC using the PCR (unpublished
data) and anti-IL-10 mAb added to IFN-y treated TEC was
incapable of restoring K! T cell proliferation. Thus, we con-
clude that TGF/3 and IL-b on TEC are not responsible for the
loss of the ability of IFN-y treated TEC to promote KI T cell
proliferation.
The mechanism by which IFN-y treated TEC impart an
inhibitory signal to autoreactive K! T cells is reversible. The
induction of unresponsive CD4+ T cell clones by IFN-y stim-
ulated epithelial cells is not reversed after subsequent stimula-
tion [201. Thus, CD4+ T cells remain unresponsive after
removal of IFN-y treated nonlymphoid APCs. In contrast,
inhibition of K! T cells requires continual contact with IFN-y
treated TEC. These observations suggest that the mechanism
by which unresponsiveness is acquired by autoreactive K!
CD4—, CD8— T cell clones differs from the mechanism respon-
sible for inducing anergy in CD4+ CD8— T cells. Whether this
mechanism is restricted to autoreactive K! T cells in MRL-lpr
mice or is applicable to other autoreactive T cells in other
autoimmune diseases will require additional experimentation.
Induction of MHC expression on IFN-y treated TEC is not
related to the loss of the ability of TEC to induce K! T cell
proliferation. K! T cells do not express CD4 or CD8 determi-
nants [31. Evidence that CD4— CD8— T cells may recognize
seif-peptides bound to class I or II molecules indicates that
MHC-restricted recognition may not require expression of CD4
or CD8 determinants [14, 15]. Masking class I and class II
determinants with mAbs does not modify the proliferative
response of KI T cells to TEC (unpublished observations). The
mechanism of autoantigen recognition by K! T cells has not
been elucidated. In theory, a potent autoantigenic stimulus may
bypass the requirements for CD4 or CD8 and MHC interaction
and explain the expansion and autoreactivity of these CD4—,
CD8—, B220+ T cells in MRL-lpr mice. Thus, CD4, CD8 and
MHC interactions are not required for CD4—, CD8—, B220+ T
cells to become either activated or unresponsive.
The results presented in this report may point out an apparent
paradox between the in vitro loss of autoreactive K! T cell
proliferation and the in vivo progression of MRL-lpr renal
disease. However, the interstitial infiltrate in MRL-lpr lupus
nephritis is oligoclonal, and only 50% of the T cell infiltrate is
composed of CD4—, CD8 —, B220+ T cells. Since our studies
focus on the CD4—, CD8—, B220+ autoreactive T cells and
have not examined the CD4+ T cells which are also readily
apparent, there may be additional factors that regulate K! T
cells. Furthermore, since the MRL-lpr mice do not have a
continual progressive increase in T cells in the kidney, we
would have predicted that regulatory mechanisms were respon-
sible for limiting T cell proliferation. However, since renal
disease does become progressively more severe it is possible
that the initial accumulation of K! T cells initiates a cascade of
events (induction of class II, ICAM, etc.) culminating in renal
failure.
In summary, IFN-y secreted by autoreactive KI T cells
decreases the ability of TEC to promote proliferation. We
speculate that the ability of K! T cells to alter the stimulator cell
(TEC) properties may represent a self-regulatory mechanism
for MRL-/pr autoreactive KI T cells. Given that autoreactive
+
+ +
+ + +
/ // // ///'/ /- - /,
*/
0 1 2 3 4 5
cpm x 10-i
Fig. 6. Surface bound IFN--y on TEC is not
responsible for reducing KI T cell clone
proljferation. TEC stimulated with IFN-y (5 Xio cells/well) were pre-treated for 1 hour with
saturating concentrations of anti-IFN-y mAb
prior to 3 days of co-culture with H-b T cells
(1 x io cells/well), The experiment was
repeated three times with similar results.
* P < 0.001.
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KI T cells proliferate to TEC in renal interstitium, we would
envision that once a critical number of these T cells accumulate,
they secrete a sufficient amount of IFN-y to limit their own
expansion. Whether this mechanism is specific for MRL-/pr T
cells or is responsible for limiting the autoreactivity of other T
cells both in the MRL-lpr mouse and other autoimmune dis-
eases should be explored.
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